Skip to main content
SpringerLink
Log in

Genetic polymorphisms may contribute to the susceptibility for acute coronary syndromes (ACS) observed in some NSAID users,

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. St Germaine CG, Bogaty P, Boyer L, Hanley J, Engert JC, Brophy JM.Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs. American Journal of Cardiology 105: 1740-5, No. 12, 15 Jun 2010. Available from: URL: http://dx.doi.org/10.1016/j.amjcard.2010.01.352

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Genetic polymorphisms may contribute to the susceptibility for acute coronary syndromes (ACS) observed in some NSAID users,. React. Wkly. 1312, 5 (2010). https://doi.org/10.2165/00128415-201013120-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013120-00013

Keywords

Search

Navigation